• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Archer Pharmaceuticals, Inc. - Product Pipeline Review - 2012 Product Image

Archer Pharmaceuticals, Inc. - Product Pipeline Review - 2012

  • ID: 2233739
  • August 2012
  • 20 pages
  • Global Markets Direct

Archer Pharmaceuticals, Inc. – Product Pipeline Review – 2012

Summary

Global Markets Direct’s pharmaceuticals report, “Archer Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Archer Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Archer Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Archer Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Archer Pharmaceuticals, Inc. - Brief Archer Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Archer Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage READ MORE >

2
List of Tables 3
List of Figures 3
Archer Pharmaceuticals, Inc. Snapshot 4
Archer Pharmaceuticals, Inc. Overview 4
Key Information 4
Key Facts 4
Archer Pharmaceuticals, Inc. – Research and Development Overview 5
Key Therapeutic Areas 5
Archer Pharmaceuticals, Inc. – Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products – Monotherapy 8
Archer Pharmaceuticals, Inc. – Pipeline Products Glance 9
Archer Pharmaceuticals, Inc. – Late Stage Pipeline 9
Phase III Products/Combination Treatment Modalities 9
Archer Pharmaceuticals, Inc. – Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
Archer Pharmaceuticals, Inc. – Drug Profiles 11
ARC-069 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
ARC029 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
ARC031 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
ARC031 SR 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
ARC050 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Archer Pharmaceuticals, Inc. – Pipeline Products By Mechanism of Action 17
Archer Pharmaceuticals, Inc. – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
Coverage 19
Secondary Research 19
Primary Research 19
Expert Panel Validation 19
Contact Us 20
Disclaimer 20

List of Tables
Archer Pharmaceuticals, Inc., Key Information 4
Archer Pharmaceuticals, Inc., Key Facts 4
Archer Pharmaceuticals, Inc. – Pipeline by Indication, 2012 6
Archer Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2012 7
Archer Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2012 8
Archer Pharmaceuticals, Inc. – Phase III, 2012 9
Archer Pharmaceuticals, Inc. – Pre-Clinical, 2012 10
Archer Pharmaceuticals, Inc. – Pipeline Products By Mechanism of Action, 2012 17

List of Figures
Archer Pharmaceuticals, Inc. – Pipeline by Indication, 2012 6
Archer Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2012 7
Archer Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2012 8
Archer Pharmaceuticals, Inc. - Pipeline Products By Mechanism of Action, 2012 17

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos